-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
Kinnate Biopharma Inc. annual/quarterly Return On Assets history and growth rate from Q3 2021 to Q4 2022.
- Kinnate Biopharma Inc. Return On Assets for the quarter ending December 31, 2022 was -37.1 %, a 59.6% decline year-over-year.
- Kinnate Biopharma Inc. annual Return On Assets for 2023 was -54.7 %, a 47.3% decline from 2022.
- Kinnate Biopharma Inc. annual Return On Assets for 2022 was -37.1 %, a 59.6% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)